Chronic inflammatory demyelinating polyneuropathy (CIDP) is an autoimmune disorder of the peripheral nervous system characterized by the weakness and impaired sensory function in the arms and legs. This disorder is caused by damage to the myelin sheath, a fatty covering that wraps and protects nerve fibers. The nerves stimulate muscle contraction and transmit sensory information to the brain through electrical impulses. Myelin acts as an insulation and allows efficient flow of electrical impulses through the nerve fibers. In patients suffering from CIDP the immune system damages or destroys the myelin due to which the nerve fibers become weak, this leads to loss or weakening of the electrical impulses in the arms and legs and cause weakness or loss of sensation. CIDP can occur at any age and in both genders. However the frequency of incidence is high among men as compared to women. The rate of recovery of the patient depends on the early diagnosis of the disease. Most CIDP patients respond well to the therapy if it is provided at the early stage of onset of the disorder so that the damage to the peripheral nerves can be controlled which contributes to the improved function and better quality of life for the patient.   

With increasing number of new cases of  CIDP and absence of permanent treatment is increasing the prevalence rate of CIDP globally. According to the American Association of Neuromuscular & Electrodiagnostic Medicine approximately 40,000 patients in the U.S. are affected by CIDP at any one time in time. The growing prevalence rate is expected to boost demand for CIDP treatment over the forecast period. Growing research in the field of CIDP treatment is expected to deliver new drugs which in turn is expected to increase the demand for CIDP treatment drugs over the forecast period. As per the clinicaltrials.gov currently there are 38 ongoing clinical trials for CIDP treatment. Organizations like GBS/CIDP Foundation International are focusing on creating awareness about CIDP and similar disorders by providing support to the patients and their families and caregivers and are focusing on development of national and international support groups. Awareness and support initiatives are expected to propel revenue growth. However the awareness initiatives are gaining traction in developed economies the awareness of CIDP and related treatments remain low in emerging low income economies. 

The CIDP treatment market is segmented by treatment type and by geography. By treatment type the global CIDP treatment market is segmented into corticosteroids, intravenous immunoglobulin and plasmapheresis (plasma exchange). Along with the primary treatment methods physicians also opt for of the treatments like chemotherapy, physiotherapy for strengthening the muscles. The secondary treatments are mainly preferred when primary treatments fail or exhibit side effects on the patient’s health.

By geography the global CIDP treatment market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific (APAC) and Middle East and Africa (MEA). North America and Europe are expected to dominate the CIDP treatment market over the forecast period. Increasing research and awareness programs are expected to promote revenue growth of CIDP treatment market in these regions.  Asia Pacific CIDP treatment market is expected to witness high growth owing to high population which in turn is expected to increase the prevalence rate of CIDP in this region. Latin America and MEA are expected to follow up with the other regions owing to growing awareness, growing healthcare infrastructure and increasing per capita healthcare spending.

Some key participants in the CIDP treatment market are Baxter International Inc., Kedrion S.p.A, Octapharma AG, CSL Behring, Grifols, S.A. and others.

This intelligence report by TMR is the outcome of intense study and rigorous assessment of various dynamics shaping the growth of the market. TMR nurtures a close-knit team of analysts, strategists, and industry experts who offer clients tools, methodologies, and frameworks to make smarter decisions. Our objective, insights, and actionable analytics provide CXOs and executives to advance their mission-critical priorities with confidence.

The scrutiny of the various forces impacting the dynamics of the market, and key and associated industries, guides enterprises in understanding various consumer propositions. Our clients leverage these insights and perspectives to enhance customer experience in the fast-paced business environment.

All our insights and perspectives are broadly based on 4 Pillars or Stages: ASBC-S, which offer an elaborate and customizable framework for the success of an organization. The essence and the roles of these in organizational successes are highlighted below:

  • Agenda for CXOs: TMR, through the study, sets the tone for agendas that are pertinent to CEOs, CFOs, CIOs, and other CXO executives of businesses operating in the market. The perspectives help our clients to bridge the gap between agenda and action plan. TMR strives to offer guidance to CXOs to undertake mission-critical activities empowered by various business analysis tools, and boost the performance of the organizations. The perspectives guide you to decide on your own marketing mix that align well with the policies, visions, and mission.
  • Strategic Frameworks: The study offers how organizations are setting both short-term and long-term strategic plans. Our team of experts collaborate and communicate with you to understand these to make your organizations sustainable and resilient during tough times. The insights help them decide sustainable competitive advantage for each business units.
  • Benchmarking for Deciding Target Markets and Brand Positioning: The assessments in the study provides a scrutiny of marketing channels and marketing mix. Our various teams work synergistically with you to help identify your actual and potential direct, indirect, and budget competition areas. Additionally, the study helps you decide most effective budgets for various processes and promotional activities. Furthermore, the study guides you to set benchmarks for integrating people and processes with the 4Ps of marketing. Eventually, this will empower you to find out unique propositioning strategies and niches.
  • Business Composability for Sustainability (C-S): Constant strategy planning for sustainability characterizing our C-S framework in the report has become more relevant than before in the face of disruptions caused by pandemics, recessions, boom and bust cycles, and changing geopolitical scenario. The TMR study offers a high level of customization to help you achieve business composability. Composable enterprises are increasingly gaining the attention of CXOs in order to help them combat market volatility. Our analysts and industry experts help you wade through such uncertainties and guide you to become a smart sustainable business in entirety.

The study presents scrutiny of region-specific consumer and technology trends, including the most recent industry dynamics. These broadly cover but not limited to

  • North America, South America, and the Americas
  • Asia Pacific and Japan
  • Europe
  • Latin America
  • Middle East and Africa

The study offers data-driven insights and guidance of several aspects. Some of the more notable questions are:

  • What are the major recent trends that can influence the product life cycle and the RoI?
  • Which regulatory trends shape corporate-level, business-level, and functional-level strategies?
  • Which micromarketing initiatives of leading players will bring in investments?
  • What can be the best framework and tools for PESTLE analysis?
  • Which regions will witness rise in new opportunities?
  • Which are the game-changing technologies being used to capture new revenue streams in the near future?
  • Which operational and tactical frameworks are being adopted by various players in gaining customer loyalty?
  • What is the current and expected intensity of competition the market in the near future?

Disclaimer: This market research study is an ongoing effort and extreme care has been taken to maintain the highest levels of accuracy at all stages. However, in the light of the rapidly evolving business dynamics, some region-specific or other segment-specific changes may take time to be part of the study.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Treatment Market